Skip to main content
. 2020 Nov 4;10(11):e036854. doi: 10.1136/bmjopen-2020-036854

Table 1.

Comorbidities in patients with ovarian cancer (n=109)

Comorbidity %
Hypertensive diseases (ie, hypertension) 28
Ischaemic heart diseases (ie, angina pectoris, myocardial infarction (>6 months), percutaneous transluminal coronary angioplasty, coronary artery bypass grafting) 6
Other forms of heart disease (ie, atrial fibrillation and flutter, other cardiac arrhythmias, heart failure, other forms of heart disease not specified) 9
Cerebrovascular diseases (ie, stroke, not specified as haemorrhage or infarction) 4
Diseases of arteries, arterioles and capillaries (ie, aortic aneurysm, peripheral vascular diseases) 3
Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (ie, phlebitis and thrombophlebitis) 1
Chronic lower respiratory diseases (ie, chronic obstructive pulmonary disease, asthma) 16
Diabetes mellitus (unspecified) 8
Disorders of thyroid gland (ie, hypothyroidism/hyperthyroidism) 6
Disorders of other endocrine glands (ie, hypoparathyroidism/hyperparathyroidism) 1
Episodic and paroxysmal disorders (ie, transient ischaemic attack) 1
Other disorders of the nervous system (unspecified) 1
Dementia in other diseases classified elsewhere (ie, dementia in Parkinson’s disease) 1
Diseases of liver (unspecified) 1
Disorders of gallbladder, biliary tract and pancreas (ie, cholelithiasis) 5
Renal failure (unspecified) 1
Soft tissue disorders (ie, rheumatism, unspecified) 2
Tuberculosis 1
Malignant neoplasms (excluding basal cell carcinoma) 7